Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization

被引:280
作者
Reseland, JE
Syversen, U
Bakke, I
Qvigstad, G
Eide, LG
Hjertner, O
Gordeladze, JO
Drevon, CA
机构
[1] Univ Oslo, Inst Nutr Res, N-0316 Oslo, Norway
[2] Univ Sci & Technol, Dept Intraabdominal Dis, Trondheim, Norway
[3] Univ Sci & Technol, Dept Physiol & Biomed Engn, Trondheim, Norway
[4] Univ Sci & Technol, Dept Canc Res & Mol Biol, Trondheim, Norway
[5] Univ Oslo, Dept Med Biochem, Oslo, Norway
关键词
leptin; leptin receptor; osteoblasts; osteosarcomas;
D O I
10.1359/jbmr.2001.16.8.1426
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The adipose hormone leptin and its receptor are important for regulation of food intake and energy metabolism. Leptin also is involved in the growth of different tissues. In this study, we show the expression of leptin in primary cultures of normal human osteoblasts (hOBs) as evidenced by reverse transcriptase-polymerase chain reaction (RT-PCR) and immunocytochemistry. Release of leptin into the medium also was found. Leptin was not detected in commercially available hOBs (NHOst) or in three different human monoclonal osteosarcoma cell lines. Leptin expression was observed in OBs in the mineralization and/or the osteocyte transition period but not during the matrix maturation period. Furthermore, hOBs and osteosarcoma cell lines expressed the long signal-transducing form of the leptin receptor (OB-Rb) as shown by RT-PCR. We observed no significant changes in leptin or OB-Rb genes in hOBs after incubation with recombinant leptin, indicating no autoregulation of the leptin expression. Incubation of both hOBs entering the mineralization phase and osteosarcoma cell lines with recombinant leptin markedly increased the number of mineralized nodules as shown by alizarin S staining. These findings indicate that leptin may be of importance for osteoblastic cell growth and bone mineralization.
引用
收藏
页码:1426 / 1433
页数:8
相关论文
共 34 条
[1]  
Bassilana F, 2000, J BONE MINER RES, V15, pS378
[2]   THE USE OF MULTICELLULAR SPHEROIDS IN ESTABLISHING HUMAN SARCOMA CELL-LINES INVITRO [J].
BRULAND, O ;
FODSTAD, O ;
PIHL, A .
INTERNATIONAL JOURNAL OF CANCER, 1985, 35 (06) :793-798
[3]   PHYSICAL-ACTIVITY, MUSCLE STRENGTH, AND CALCIUM INTAKE IN FRACTURE OF THE PROXIMAL FEMUR IN BRITAIN [J].
COOPER, C ;
BARKER, DJP ;
WICKHAM, C .
BRITISH MEDICAL JOURNAL, 1988, 297 (6661) :1443-1446
[4]  
DAHL LK, 1952, P SOC EXP BIOL MED, V80, P474, DOI 10.3181/00379727-80-19661
[5]   Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass [J].
Ducy, P ;
Amling, M ;
Takeda, S ;
Priemel, M ;
Schilling, AF ;
Beil, FT ;
Shen, JH ;
Vinson, C ;
Rueger, JM ;
Karsenty, G .
CELL, 2000, 100 (02) :197-207
[6]   CHARACTERISTICS OF A CELL-LINE ESTABLISHED FROM A PATIENT WITH MULTIPLE OSTEOSARCOMA, APPEARING 13 YEARS AFTER TREATMENT FOR BILATERAL RETINOBLASTOMA [J].
FODSTAD, O ;
BROGGER, A ;
BRULAND, O ;
SOLHEIM, OP ;
NESLAND, JM ;
PIHL, A .
INTERNATIONAL JOURNAL OF CANCER, 1986, 38 (01) :33-40
[7]   Differentiation of human marrow stromal precursor cells: Bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation [J].
Gori, F ;
Thomas, T ;
Hicok, KC ;
Spelsberg, TC ;
Riggs, BL .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (09) :1522-1535
[8]   Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women [J].
Goulding, A ;
Taylor, RW .
CALCIFIED TISSUE INTERNATIONAL, 1998, 63 (06) :456-458
[9]   Leptin and leptin receptor mRNA and protein expression in the murine fetus and placenta [J].
Hoggard, N ;
Hunter, L ;
Duncan, JS ;
Williams, LM ;
Trayhurn, P ;
Mercer, JG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) :11073-11078
[10]   Postmenopausal bone mineral density: Relationship to calcium intake, calcium absorption, residual estrogen, body composition, and physical activity [J].
Hoover, PA ;
Webber, CE ;
Beaumont, LF ;
Blake, JM .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1996, 74 (08) :911-917